• SENSEX 73,832.75
    586.72 (+0.80%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,490.00 1,423.80(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • NSE
    1,795.00 1,878.00(%)
  • Aeroflex
    579.00 613.50(%)
  • The Bombay Burmah
    1,203.00 2,050.25(%)
  • Pidilite Inds.
    1,344.00 1,259.45(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    931.00 1,177.60(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • Birlasoft Ltd
    345.00 473.75(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • JSW Dulux
    286.50 374.67(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • Acutaas Chemical
    4,000.00 3,977.00(%)
  • Adani Ports
    1,839.80 1,891.80(%)
  • Moneyview
    52.44 65.43(%)
  • Tonbo Imaging
    1,175.75 1,013.95(%)
  • Apollo Hospitals
    8,239.00 9,326.80(%)
  • DLF
    674.90 786.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vaishali Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71078.0
  • ISIN : INE972X01022
6.82 0 (-3.94%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    6.73

  • Today’s High

    7.33

  • Open

    6.92

  • Perv Close

    7.10

  • 52W Low

    4.75

  • 52W High

    11.15

Key Indicators

  • P/E(TTM)

    22.00

  • Mar.Cap (₹Cr.)

    92.07

  • Div & Yield %

    0.00

  • Book Value(₹)

    5.78

  • Debt-Equity Ratio

    -3.94

  • AGM Date

    28-Oct-2026

  • EPS

    0.31

  • P/E Ratio

    22.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    92.07

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    27.00

  • BV (₹)

    5.80

  • Sales( ₹ in Cr.)

    108.77

  • NP (in Cr.)

    4.03

  • NP Var(%)

    393.0

  • Div%

    0.0

  • CPS (₹)

    0.30

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    92.07

  • 52 Week High

    11.15

  • 52 Week Low

    4.75

  • Price BSE

    0.0

  • Price NSE

    7.00

  • Market Capital( in Cr.)

    92.07

  • P/C Ratio

    20.40

  • P/E Ratio

    23.40

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 108.77 99.03 86.28 69.66 75.82 53.77
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 108.77 99.03 86.28 69.66 75.82 53.77
Other Income 3.84 3.21 2.03 2.23 1.79 1.81
Stock Adjustments -1.41 4.43 -2.67 2.42 0.04 -0.29
Total Income 111.20 106.67 85.64 74.31 77.65 55.29
EXPENDITURE :            
Raw Materials 93.71 90.10 71.75 57.10 63.54 45.86
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 1.66 1.58 1.40 1.30 1.36 1.19
Other Manufacturing Expenses 0.08 0.09 0.02 0.02 0.02 0.02
Selling and Administration Expenses 5.66 5.57 3.42 4.28 4.06 1.94
Miscellaneous Expenses 2.12 5.54 5.35 0.00 0.00 1.82
Employee Benefit Expenses 1.66 1.58 1.40 1.30 1.36 1.19
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 103.22 102.88 81.95 62.71 68.97 50.83
Operating Profit 7.97 3.78 3.70 11.61 8.67 4.46
Interest 1.98 2.07 2.27 2.26 2.49 2.63
Gross Profit 5.99 1.71 1.43 9.35 6.18 1.83
Depreciation 0.60 0.49 0.51 0.50 0.46 0.43
Profit Before Tax 5.39 1.22 0.92 8.85 5.72 1.40
Current Tax 1.34 0.42 0.25 2.24 1.72 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 -0.01 -0.04 0.00 -0.02 -0.02
Reported Net Profit 4.03 0.82 0.72 6.60 4.02 1.05
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 4.03 0.82 0.72 6.60 4.02 1.05
Adjustment below Net Profit 0.04 0.00 0.02 0.00 0.00 0.00
P & L Balance brought forward 15.91 15.09 14.35 7.59 3.57 2.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 19.98 15.91 15.09 14.19 7.59 3.57
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.31 0.06 0.67 6.26 3.82 0.99
Earnings Per Share(Adj)-Unit Curr 0.31 0.06 0.67 6.26 3.82 0.99
Book Value 5.29 4.98 33.41 38.43 24.99 21.26
Book Value(Adj)-Unit Curr 5.29 4.98 33.41 38.43 24.99 21.26

Shareholding Pattern

  • Promoter Group

    31.61%

  • Public Share Holding

    68.39%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 2,500,050 1.92 2,500,050 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 38,735,240 29.69 38,735,240 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 41,235,290 31.61 41,235,290 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 4,100,017 3.14 4,100,017 47
Clearing Members 129,481 0.10 129,481 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 523,617 0.40 523,617 174
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,279,797 2.51 3,279,797 326
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 44,613,370 34.20 44,613,370 92
Individuals holding nominal share capital up to Rs. 1 lakh 36,575,478 28.04 36,575,478 26,043
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 89,226,840 68.39 89,226,840 26,692
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 130,462,130 100.00 130,462,130 26,702

Company Background

Vaishali Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vaishali Pharma Ltd
  • BSE Code : 71078.0
  • ISIN : INE972X01022

  • Incorporation Year

    2008

  • Registered Office

    706 to 709 7th Floor Aravali
    Business Centre Borivali(W), Mumbai,
    Maharashtra-400092

  • Telephone

    91-22-28928833

  • FAX

    91-22-28928833

  • Chairman

    Atul Vasani

  • Managing Director

    Atul Vasani

  • Company Secretary

    Vishwa Mekhia

  • Auditor

    Raman S Shah & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Vaishali Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vaishali Pharma 6.82 112.61 108.77 22.00 8.90
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77